LifePoint Health, Inc. (NASDAQ:LPNT) Q4 2015 Earnings Conference Call - Final Transcript
Feb 12, 2016 • 10:00 am ET
Ladies and gentlemen, thank you for standing by, and welcome to the LifePoint Health Fourth Quarter and Year-End 2015 Earnings Conference Call.
On today's call, LifePoint will be making forward-looking statements based on management's current expectations. Numerous factors could cause LifePoint results to differ from those expectations, and LifePoint has outlined these factors in its filings with the SEC. The company encourages you to review these filings. LifePoint also asks that you please review the cautionary language under the caption, Important Legal Information, in the company's press release issued this morning.
The company undertakes no obligation to update or make any other forward-looking statements whether as a result of new information, future events, or otherwise. Also, please visit LifePoint's website for links to various information and filings.
During this presentation, all participants are in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded on Friday, February 12, 2016.
It's now my pleasure to turn the conference over to Bill Carpenter, Chairman and Chief Executive Officer at LifePoint Health. Please go ahead, sir.
Great. Thank you. Welcome everyone to LifePoint Health's fourth quarter and full-year 2015 earnings call. We hope you've had a chance to review the press release we issued earlier this morning. I'll begin by taking you through some of the highlights from the fourth quarter and the year, and then I'll hand the call over to Leif Murphy, our Chief Financial Officer, for a closer look at our financial performance. Following our prepared remarks, Leif and I, as well as David Dill, our President and Chief Operating Officer, will be available to answer your questions.
We're pleased with our results, which were in line with our expectations. For the quarter, revenues from consolidated operations were $1.37 billion, an increase of approximately 8% over last year. Adjusted EBITDA was $184.2 million, up by approximately 6% from a year ago. And diluted earnings per share as adjusted were $1.11, an increase of approximately 3% over the fourth quarter of 2014. Same-hospital admissions were down 4.2% in the fourth quarter and equivalent admissions were down 1.1%.
As I'm sure everyone has seen, this has been a very mild flu season, which makes year-over-year volume comparisons challenging. While a mild flu season impacts volumes, these cases tend to be low acuity and have little effect on our financial results.
Turning to the full-year; LifePoint achieved record revenue, EBITDA, and adjusted diluted EPS in 2015. Our revenues were approximately $5.2 billion, up 16% from 2014. Adjusted EBITDA from consolidated operations was $705.7 million, an 11% increase from last year. And diluted earnings per share as adjusted were $4.09, an increase of 19% over 2014.
2015 was a transformative year for LifePoint. Our acquisition strategy is really taking hold and we anticipate our recent acquisitions will be significant contributors to the bottom line in the years ahead. It also was a year in which we made great progress as a national leader in the